313 related articles for article (PubMed ID: 34684780)
41. Searching possible SARS-CoV-2 main protease inhibitors in constituents from herbal medicines using
Rasul HO; Thomas NV; Ghafour DD; Aziz BK; Salgado M G; Mendoza-Huizar LH; Candia LG
J Biomol Struct Dyn; 2024 May; 42(8):4234-4248. PubMed ID: 37349945
[TBL] [Abstract][Full Text] [Related]
42. Establishing an Analogue Based In Silico Pipeline in the Pursuit of Novel Inhibitory Scaffolds against the SARS Coronavirus 2 Papain-Like Protease.
Hajbabaie R; Harper MT; Rahman T
Molecules; 2021 Feb; 26(4):. PubMed ID: 33672721
[TBL] [Abstract][Full Text] [Related]
43. Computational Selectivity Assessment of Protease Inhibitors against SARS-CoV-2.
Fischer A; Sellner M; Mitusińska K; Bzówka M; Lill MA; Góra A; Smieško M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669738
[TBL] [Abstract][Full Text] [Related]
44. Rational Approach toward COVID-19's Main Protease Inhibitors: A Hierarchical Biochemoinformatics Analysis.
Bastos RS; de Aguiar CPO; Cruz JN; Ramos RS; Kimani NM; de Souza JSN; Chaves MH; de Freitas HF; Pita SSR; Santos CBRD
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928422
[TBL] [Abstract][Full Text] [Related]
45. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
[TBL] [Abstract][Full Text] [Related]
46. Structure-Based Identification of Naphthoquinones and Derivatives as Novel Inhibitors of Main Protease M
Santos LH; Kronenberger T; Almeida RG; Silva EB; Rocha REO; Oliveira JC; Barreto LV; Skinner D; Fajtová P; Giardini MA; Woodworth B; Bardine C; Lourenço AL; Craik CS; Poso A; Podust LM; McKerrow JH; Siqueira-Neto JL; O'Donoghue AJ; da Silva Júnior EN; Ferreira RS
J Chem Inf Model; 2022 Dec; 62(24):6553-6573. PubMed ID: 35960688
[TBL] [Abstract][Full Text] [Related]
47. Machine learning combines atomistic simulations to predict SARS-CoV-2 Mpro inhibitors from natural compounds.
Nguyen TH; Thai QM; Pham MQ; Minh PTH; Phung HTT
Mol Divers; 2024 Apr; 28(2):553-561. PubMed ID: 36823394
[TBL] [Abstract][Full Text] [Related]
48. Computational screening for potential drug candidates against the SARS-CoV-2 main protease.
Silva Andrade B; Ghosh P; Barh D; Tiwari S; José Santana Silva R; Rodrigues de Assis Soares W; Silva Melo T; Santos Freitas A; González-Grande P; Sousa Palmeira L; Carlos Junior Alcantara L; Giovanetti M; Góes-Neto A; Ariston de Carvalho Azevedo V
F1000Res; 2020; 9():. PubMed ID: 33447372
[No Abstract] [Full Text] [Related]
49. Anisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation.
Kar P; Kumar V; Vellingiri B; Sen A; Jaishee N; Anandraj A; Malhotra H; Bhattacharyya S; Mukhopadhyay S; Kinoshita M; Govindasamy V; Roy A; Naidoo D; Subramaniam MD
J Biomol Struct Dyn; 2022 Jul; 40(10):4532-4542. PubMed ID: 33305988
[TBL] [Abstract][Full Text] [Related]
50. Investigating the structure-activity relationship of marine polycyclic batzelladine alkaloids as promising inhibitors for SARS-CoV-2 main protease (M
Elgohary AM; Elfiky AA; Pereira F; Abd El-Aziz TM; Sobeh M; Arafa RK; El-Demerdash A
Comput Biol Med; 2022 Aug; 147():105738. PubMed ID: 35777088
[TBL] [Abstract][Full Text] [Related]
51. Identification of Potential SARS-CoV-2 Main Protease and Spike Protein Inhibitors from the Genus
Abouelela ME; Assaf HK; Abdelhamid RA; Elkhyat ES; Sayed AM; Oszako T; Belbahri L; El Zowalaty AE; Abdelkader MSA
Molecules; 2021 Mar; 26(6):. PubMed ID: 33801151
[TBL] [Abstract][Full Text] [Related]
52. A molecular modelling approach for identifying antiviral selenium-containing heterocyclic compounds that inhibit the main protease of SARS-CoV-2: an in silico investigation.
Rakib A; Nain Z; Sami SA; Mahmud S; Islam A; Ahmed S; Siddiqui ABF; Babu SMOF; Hossain P; Shahriar A; Nainu F; Emran TB; Simal-Gandara J
Brief Bioinform; 2021 Mar; 22(2):1476-1498. PubMed ID: 33623995
[TBL] [Abstract][Full Text] [Related]
53. Repurposing of antimycobacterium drugs for COVID-19 treatment by targeting SARS CoV-2 main protease: An in-silico perspective.
Chakraborty A; Ghosh R; Soumya Mohapatra S; Barik S; Biswas A; Chowdhuri S
Gene; 2024 Sep; 922():148553. PubMed ID: 38734190
[TBL] [Abstract][Full Text] [Related]
54. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation.
Choudhary MI; Shaikh M; Tul-Wahab A; Ur-Rahman A
PLoS One; 2020; 15(7):e0235030. PubMed ID: 32706783
[TBL] [Abstract][Full Text] [Related]
55. A Computational Approach to Explore the Interaction of Semisynthetic Nitrogenous Heterocyclic Compounds with the SARS-CoV-2 Main Protease.
Llanes A; Cruz H; Nguyen VD; Larionov OV; Fernández PL
Biomolecules; 2020 Dec; 11(1):. PubMed ID: 33375460
[TBL] [Abstract][Full Text] [Related]
56. Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188.
Lockbaum GJ; Reyes AC; Lee JM; Tilvawala R; Nalivaika EA; Ali A; Kurt Yilmaz N; Thompson PR; Schiffer CA
Viruses; 2021 Jan; 13(2):. PubMed ID: 33503819
[TBL] [Abstract][Full Text] [Related]
57. Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M
Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM
Life Sci; 2020 Aug; 255():117831. PubMed ID: 32450166
[TBL] [Abstract][Full Text] [Related]
58. Shedding Light on Dark Chemical Matter: The Discovery of a SARS-CoV-2 M
Peralta-Moreno MN; Mena Y; Ortega-Alarcon D; Jimenez-Alesanco A; Vega S; Abian O; Velazquez-Campoy A; Thomson TM; Pinto M; Granadino-Roldán JM; Santos Tomas M; Perez JJ; Rubio-Martinez J
Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892306
[TBL] [Abstract][Full Text] [Related]
59. Synthetic flavonoids as potential antiviral agents against SARS-CoV-2 main protease.
Batool F; Mughal EU; Zia K; Sadiq A; Naeem N; Javid A; Ul-Haq Z; Saeed M
J Biomol Struct Dyn; 2022 May; 40(8):3777-3788. PubMed ID: 33251983
[TBL] [Abstract][Full Text] [Related]
60.
Rudrapal M; Issahaku AR; Agoni C; Bendale AR; Nagar A; Soliman MES; Lokwani D
J Biomol Struct Dyn; 2022; 40(20):10437-10453. PubMed ID: 34182889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]